Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants

This study has been terminated.
(one of site was not able to get an approval from the national regulatory authority.)
Sponsor:
Collaborators:
International Centre for Diarrhoeal Disease Research, Bangladesh
Christian Medical College, Vellore, India
Avant Immunotherapeutics
Vaccine Technologies, Inc.
Information provided by (Responsible Party):
International Vaccine Institute
ClinicalTrials.gov Identifier:
NCT00624975
First received: February 19, 2008
Last updated: July 30, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)